HealthEquity, Inc.
Bear Case (25th pct.)
-55.9% vs price
Base Case (Median)
-44.5% vs price
Bull Case (75th pct.)
-15.6% vs price
◇ = Current price | |Bear |Base | Bull
| Method | Est. Value | vs Price | Weight |
|---|---|---|---|
| DCF (Discounted Cash Flow) | $51.86 | -49.3% | High (40%) |
| PE Comparable | $59.42 | -41.9% | Medium (25%) |
| Growth Trajectory DCF | $555.11 | 442.5% | Medium (20%) |
| Graham Number | $38.34 | -62.5% | Medium (40%) |
| EV/EBITDA | $56.80 | -44.5% | Medium (20%) |
| EV/FCF | $113.23 | 10.7% | Medium (20%) |
| Earnings Power Value | $28.07 | -72.6% | Medium (50%) |
Based on 7 out of 8 methods, HQY appears overvalued at the current price of $102.33. The base case fair value of $56.80 implies 44.5% downside.
Bear/base/bull cases represent the 25th, 50th, and 75th percentile of available method estimates. This is not financial advice. Valuation is inherently uncertain.